ASP Isotopes Inc. to Post FY2025 Earnings of ($0.07) Per Share, HC Wainwright Forecasts (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) – Investment analysts at HC Wainwright issued their FY2025 EPS estimates for ASP Isotopes in a research note issued on Wednesday, April 17th. HC Wainwright analyst H. Ihle forecasts that the company will earn ($0.07) per share for the year. HC Wainwright has a “Buy” rating and a $5.50 price target on the stock. The consensus estimate for ASP Isotopes’ current full-year earnings is $0.07 per share.

ASP Isotopes Stock Performance

NASDAQ:ASPI opened at $3.10 on Thursday. ASP Isotopes has a 12-month low of $0.28 and a 12-month high of $4.97. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $151.65 million, a PE ratio of -6.33 and a beta of 5.03. The firm has a 50-day moving average price of $3.67 and a 200 day moving average price of $2.40.

Institutional Trading of ASP Isotopes

Large investors have recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new stake in ASP Isotopes during the fourth quarter worth about $26,000. Millennium Management LLC bought a new stake in ASP Isotopes during the fourth quarter worth about $49,000. HTLF Bank bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $141,000. Citadel Advisors LLC bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $187,000. Finally, Rathbones Group PLC bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $272,000. 16.80% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Robert John Andrew Ryan acquired 15,596 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were purchased at an average cost of $2.35 per share, with a total value of $36,650.60. Following the completion of the purchase, the director now owns 537,055 shares of the company’s stock, valued at $1,262,079.25. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 26.30% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.